169 Infos zu Ignace Vergote

Mehr erfahren über Ignace Vergote

Lebt in

Infos zu

12 Aktuelle Nachrichten

‘Er is hoop voor kankerpatiënten' | Het Nieuwsblad

‘Moleculaire kankertherapie is de toekomst. Het zorgt voor minder bijwerkingen dan chemo, is efficiënter en bestaat intussen zo goed als voor alle kankers'...

"Met deze nieuwe therapie roeien we kanker uit" - Gazet van Antwerpen

... kunnen we steeds meer patiënten helpen bij steeds meer verschillende vormen van kanker”, zegt professoroncoloog Ignace Vergote (foto).

Prima BioMed Announces Significant Updates to Its Clinical Advisory...

Prima BioMed Announces Significant Updates to Its Clinical Advisory Board: Eric Pujade-Lauraine, Christian Marth, and Ignace Vergote Join Esteemed Group of Gynecology ...

Alle artikels over "Ignace Vergote" - Data News.be

Alle artikels over het onderwerp

7 Profile in Sozialen Netzwerken

LinkedIn: Ignace Vergote | LinkedIn

View Ignace Vergote's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ignace Vergote discover ...

LinkedIn: Ignace Vergote - Professor - K.U.Leuven | LinkedIn

View Ignace Vergote's profile on LinkedIn, the world's largest professional community. Ignace has 1 job listed on their profile. See the complete profile on ...

LinkedIn: Ignace Vergote | LinkedIn

View Ignace Vergote's (Belgium) professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ignace Vergote ...

Ignace Vergote - Amolca

› autor › ignac...

4 Hobbys & Interessen

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC ...

von I Vergote · · Zitiert von: — Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer. List of authors. Ignace Vergote, M.D., Ph.D.,; Claes G. Tropé, ... › doi › full

Gynaecological cancers - The Lancet

— In the first paper in this Series, Ignace Vergote and colleagues present the consensus recommendations from the sixth Gynecologic Cancer ... › series

Gynecologic Oncology Publishes Results of the INNOVATE Phase 2 Pilot...

Novocure announced today that the results of its INNOVATE phase 2 pilot trial have been published in Gynecologic Oncology.

1 Persönliche Webseiten

Steering Committee - IOTA Education

— Steering Committee · Dirk Timmerman · Tom Bourne · Lil Valentin · Ben Van Calster · Antonia Testa · Ignace Vergote · Sabine Van Huffel. › about › stee...

1 Angaben zur Herkunft

Ignace Vergote - The Mathematics Genealogy Project

› ...

24 Bücher zum Namen

Dendritic cell-based immunotherapy in ovarian cancer

von A Coosemans · · Zitiert von: 17 — An Coosemans is a postdoctoral research fellow supported by the FWO-V; Ignace Vergote and Stefaan W Van Gool are senior clinical investigators supported by ... › onci

Atlas of Gynaecological Cancer Surgery (Hardcover)

undefined undefined General, Surgery, Medicine, Books, Gynaecology & obstetrics, Clinical & internal medicine, Gross pathology, Pathology, Other branches of...

: Atlas of Gynaecological Cancer Surgery - Ignace...

Ignace Vergote. Published by Jaypee Brothers Medical Pub (2008). ISBN 10: ISBN 13: New Hardcover Quantity Available: 1.

Proceedings of the International Cancer Imaging Society (ICIS) 16th...

Ignace Vergote (Department of Obstretics and Gynaecology, University Hospitals Leuven) ... of Diagnostic and Interventional Radiology, University Tuebingen)

12 Dokumente

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic...

Background: Advanced recurrent or metastatic cervical cancer has a 5-year survival of only 17% and no current second-line standard-of-care, representing a signi

Professor Ignace Vergote

Professor Ignace Vergote is Head of the Department of Obstetrics and Gynaecology and Gynaecologic Oncology at the Catholic University of Leuven, Belgium.

Impact of Adjuvant Chemotherapy and Surgical Staging in ...

von JB Trimbos · · Zitiert von: 599 — Ignace Vergote,. Ignace Vergote. Search for other works by this author on: Oxford Academic · PubMed · Google Scholar. Giorgio Bolis,. Giorgio Bolis. › jnci › a...

Neoadjuvant chemotherapy in advanced ovarian cancer

Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists? Ignace Vergote. › ...

8 Wissenschaftliche Publikationen

European Journal of Cancer - ScienceDirect.com

von I Vergote · · Zitiert von: 3 — The analysis indicates that the relative clinical benefit of bevacizumab appears to be additive and consistent across regimens. Contributors. Ignace Vergote: ... › pii

dblp: Ignace Vergote

List of computer science publications by Ignace Vergote

Seminars in Oncology | New Developments in Gynecologic Malignancies |...

New Developments in Gynecologic Malignancies. Eli Lilly and company. Edited by Robert F. Ozols, Ignace Vergote. Volume 33, Supplement 6, Pages A1-A2, ...

dblp: Artificial Intelligence in Medicine, Volume 28

Bibliographic content of Artificial Intelligence in Medicine, Volume 28

9 Allgemeine Veröffentlichungen

bol.com: Alle artikelen van Ignace Vergote - Bol.com

› ignace-verg...

bol.com: bol.com | Atlas of Gynaecological Cancer Surgery | |...

Atlas of Gynaecological Cancer Hardcover. Atlas of Gynaecological Cancer Surgery is een boek van Ignace Vergote

The role of interval debulking surgery in ovarian cancer

von MEL van der Burg · · Zitiert von: 49 — Maria E. L. van der Burg MD, PhD &; Ignace Vergote MD, PhD. Current Oncology Reports volume 5, pages 473–481 (2003)Cite this article Accesses. › article

Hypertension - BioMedSearch

Barber Shaun R SR Department of Health Sciences, University of Leicester, United Kingdom Cohen Jay J BMG: The Endocrine Clinic, P.C., South Rex Road, ... Marburg; Pauline Wimberger, AGO and University of Duisburg-Essen, Essen ... Aviano, Italy; Ignace Vergote, Belgian Gynaecological Oncology Group and ...

1 Video- & Audioinhalte

NKTR-102: a new drug for treating platinum-resistant or refractory...

Professor Ignace Vergote speaks about his research into NKTR-102, a new drug for treating women with platinum-resistant/refractory ovarian cancer. In addition t

7 Meinungen & Artikel

Twitter-Nachrichten: IJGC on Twitter: "@IJGCfellows mentor's #podcast w/ Dr ...

— mentor's #podcast w/ Dr. Ignace Vergote Dr. Vergote talks about: ☑️ his career path ☑️ EORTC ☑️ What he looks for in a gynonc fellow ... › status

Wikipedia: European Society of Gynaecological Oncology – Wikipedia

Die European Society of Gynaecological Oncology (ESGO) ist eine europaweite Vereinigung ... ENGOT, European Network of Gynae Oncological Trial Groups: Ignace Vergote, Belgien. ENTRIGO, European Network of Translational Research ...

Long-term efficacy, tolerability and overall survival in patients...

Michael Friedlander ,; Ursula Matulonis ,; Charlie Gourley ,; Andreas du Bois ,; Ignace Vergote ,; Gordon Rustin ,; Clare Scott ,; Werner Meier ...

Genome-wide association study identifies a common variant associated...

Amanda Spurdle and colleagues report results of a genome-wide association study of endometrial cancer. They identify a risk variant near HNF1B that has...

81 Webfunde aus dem Netz

‪Ignace Vergote‬ - ‪Google Scholar‬

› citations

‪Ignace Vergote‬ - ‪Google Scholar‬scholar.google.com › citations

Ignace Vergote. Professor of Gynecologic Oncology, University of Leuven. Verified email at uzleuven.be. gynaecological cancer. ArticlesCited byPublic access ...Missing: Oberkirch, Baden" Ignace Vergote. Professor of Gynecologic Oncology, University of Leuven. Verified email at uzleuven.be. gynaecological cancer. ArticlesCited byPublic access ... Missing: Oberkirch, Baden"

Profiles

Ignace Vergote. Professor of Gynecologic Oncology, University of Leuven. Verified email at uzleuven.be. Cited by gynaecological cancer ...

NEOADJUVANT CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER Ateş KARATEKE...

Extensive and aggressive surgery improve survival The traditional treatment has consisted of PDS and adjuvant chemotherapy The most important factor regarding...

Alle artikels over "Ignace Vergote" - Belgian Oncology & Hematology...

Alle artikels over het onderwerp

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced...

Primary Cytoreductive Surgery Bristow et al JCO % 25mo 75% 34mo

Ignace Vergote - European Society of Gynaecological Oncology

› speakers › ignace...

Introduction Ignace Vergote, MD Department of Obstetrics and...

Surgery and carboplatin-paclitaxel iv are the cornerstones of first-line therapy 80%-85% respond to first-line therapy Newer regimens including molecular ...

Hoe gaan naar Ignace Vergote in Lubbeek via Bus of Trein?

Moovit helpt je de beste route naar Ignace Vergote te vinden met behulp van het openbaar vervoer en geeft je stap-per-stap instructies met actuele uurroosters ...

Ignace Vergote: H-index & Awards - Academic Profile

› Medicine

The Mentors Podcast with Ignace Vergote IJGC Podcast

› podcast

Ursula Matulonis and Ignace Vergote on Cervical Cancer ...

› videos › urs...

Equipe du Professeur Ignace Vergote

› project › e...

Ignace Vergote | Research Portal

Researcher. Ignace Vergote. Keywords:Medicine. Disciplines:Endocrinology and metabolic diseases, Gynaecology and obstetrics, Nursing ...

Prof. Ignace Vergote: UPDATE IN GYNAECOLOGICAL ...

› Podcasts

Team van Professor Ignace Vergote - Stichting tegen Kanker

› project › t...

Tous les articles sur "Ignace Vergote" - Belgian Oncology &...

Tous les articles avec le sujet

Ignace B. Vergote Archives | The Bulletin

› tag › igna...

Professor Ignace Vergote: Current perspectives on...

Inside Diagnostics Professor Ignace Vergote: Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients. Request your free ...

M.D. Ignace Vergote, Ph.D. » Linkos.cz

University Hospitals Leuven, Katholieke Universiteit Leuven

Bedeutung zum Vornamen Ignace

Männlicher Vorname (Französisch): Ignace; Etruskisch (Römischer Familienname); ignis = das Feuer (Lateinisch); ursprünglich ein römischer Familiennamen 'Egnatius', vielleicht mit etruskischen Wurzeln oder abgeleitet von lateinisch 'ignis' (Feuer); bekannt durch den hl. Ignatius von Loyola (15./16. Jh.), dem Gründer des Jesuitenordens

Verwandte Personensuchen

Personensuche zu Ignace Vergote & mehr

Die Personensuchmaschine Namenfinden.de ist die neue Personensuche für Deutschland, die Profile, Kontaktdaten, Bilder, Dokumente und Webseiten zu Ignace Vergote und vielen weiteren Namen aus öffentlich zugänglichen Quellen im Internet anzeigt.